Literature DB >> 17308295

Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies.

François Ducray, Richard Roos-Weil, Pierre Yves Garcia, Juliana Slesari, Olivier Heinzlef, Denis Chatelain, Philippe Toussaint, Etienne Roullet, Jérôme Honnorat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17308295      PMCID： PMC2117653          DOI： 10.1136/jnnp.2006.097972

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

Review 2.  Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.

Authors:  Shelley A Cross; Diva R Salomao; Joseph E Parisi; Thomas J Kryzer; Elizabeth A Bradley; Jonathan A Mines; Byron L Lam; Vanda A Lennon
Journal:  Ann Neurol       Date:  2003-07       Impact factor: 10.422

3.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 4.  Necrotizing myelopathy associated with malignancy. A clinicopathologic study of two cases and literature review.

Authors:  V J Ojeda
Journal:  Cancer       Date:  1984-03-01       Impact factor: 6.860

5.  Devic disease and thymoma with anti-central nervous system and antithymus antibodies.

Authors:  J C Antoine; J P Camdessanché; L Absi; F Lassablière; L Féasson
Journal:  Neurology       Date:  2004-03-23       Impact factor: 9.910
  5 in total
  11 in total

Review 1.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

2.  Neuromyelitis optica - an update: 2007-2009.

Authors:  Anu Jacob
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

Review 3.  Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica.

Authors:  Corinna Trebst; Peter Raab; Elke Verena Voss; Paulus Rommer; Mazen Abu-Mugheisib; Uwe K Zettl; Martin Stangel
Journal:  Nat Rev Neurol       Date:  2011-11-01       Impact factor: 42.937

Review 4.  Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies.

Authors:  Julien Ratelade; A S Verkman
Journal:  Int J Biochem Cell Biol       Date:  2012-06-17       Impact factor: 5.085

Review 5.  AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Nat Rev Neurol       Date:  2010-07       Impact factor: 42.937

6.  The history of neuromyelitis optica.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2013-01-15       Impact factor: 8.322

7.  Screening for onconeural antibodies in neuromyelitis optica spectrum disorders.

Authors:  Benjamin Berger; Tilman Hottenrott; Sebastian Rauer; Oliver Stich
Journal:  BMC Neurol       Date:  2017-01-10       Impact factor: 2.474

8.  Optic Neuritis: A Rare Paraneoplastic Phenomenon of Hodgkin's Lymphoma.

Authors:  Yasir Khan; Waqas Khan; Nishanth Thalambedu; Ammar A Ashfaq; Waqas Ullah
Journal:  Cureus       Date:  2019-07-20

Review 9.  Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review.

Authors:  Jinhua Yan; Zhongbo Chen; Yumei Liang; Huijia Yang; Lizhi Cao; Yuling Zhou; Yang Zhao; Ying Zhang
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

Review 10.  Neuromyelitis optica pathogenesis and aquaporin 4.

Authors:  David J Graber; Michael Levy; Douglas Kerr; William F Wade
Journal:  J Neuroinflammation       Date:  2008-05-29       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.